Healthcare
Live Price
Offline$31.92
+2.97% today
Window Change
+79.19%
Window
Sep 11, 2025 → Jun 25, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 197 bars · Sep 11, 2025 → Jun 25, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
LB Pharmaceuticals Inc Common Stock (LBRX) is a Healthcare stock with a market cap of $900.00M and listed on NASDAQ. The stock last traded around $31.92 and up 79.2% across the available one-year price window (Sep 11, 2025 → Jun 25, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +94.4%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +94.4%, free cash flow +34.5% with operating margin 0.0% and ROIC -9.9%. Stock Foundry combines LBRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
LBRX is 67.53 pts ahead over the shared 1Y window.
LBRX had 8.69 pts deeper max drawdown than SPY.
LBRX beat SPY in 2 of 2 calendar years shown and trailed in 0.
LBRX
+79.19%
Normalized return
SPY
+11.66%
S&P 500
Excess Return
+67.53 pts
Relative to SPY
LBRX Max Drawdown
-17.82%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for LBRX and SPY.
| Year | LBRX | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | +51.66% | +6.71% | +44.96 pts | LBRX |
| 2025 | +24.28% | +11.19% | +13.08 pts | LBRX |
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.